Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Ohtake

Showing results (61-70 of 93) with videos related to

Pageof 10
Sort By:
Circulatory Shock|January 1, 1985
Effects of ATP-MgCl2 and ATP-Na2 administration on renal function and cellular metabolism following renal ischemiaH Hirasawa, K Soeda, Y Ohtake, et al.
Nihon Geka Gakkai Zasshi|September 1, 1985
[Pathophysiology and treatment of multiple organ failure among hepatectomized cirrhotic patients]H Hirasawa, M Odaka, H Kobayashi, et al.
European Journal of Immunology|February 17, 2001
A complex composed of USF1 and USF2 activates the human FcepsilonRI alpha chain expression via a CAGCTG element in the first intronK Takahashi, C Nishiyama, M Nishiyama, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1991
[Hemopurification in the management of ARDS complicating multiple organ failure]H Hirasawa, T Sugai, Y Ohtake, et al.
Contributions to Nephrology|January 1, 1991
Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltrationY Ohtake, H Hirasawa, T Sugai, et al.
Clinical Nephrology|June 11, 1999
Hepatocellular carcinoma among hemodialysis patients infected with hepatitis C virus--early evolution and rapid progressionH Hayashi, Y Ohtake, T Kashima, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1983
Experimental and clinical study on ATP-MgCl2 administration for postischemic acute renal failureH Hirasawa, M Odaka, K Soeda, et al.
ASAIO Transactions|July 1, 1990
A muscle powered cardiac assist device for right ventricular support: total assist or partial assist?N Sakakibara, G Watanabe, T Misaki, et al.
Artificial Organs|October 1, 1988
Prognostic value of serum osmolality gap in patients with multiple organ failure treated with hemopurificationH Hirasawa, M Odaka, T Sugai, et al.
Biological & Pharmaceutical Bulletin|August 21, 2001
Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V2 receptor antagonistA Naito, H Hasegawa, T Kurasawa, et al.
Pageof 10

Showing results (61-70 of 93) with videos related to

Sort By:
Pageof 10
Circulatory Shock|January 1, 1985
Effects of ATP-MgCl2 and ATP-Na2 administration on renal function and cellular metabolism following renal ischemiaH Hirasawa, K Soeda, Y Ohtake, et al.
Nihon Geka Gakkai Zasshi|September 1, 1985
[Pathophysiology and treatment of multiple organ failure among hepatectomized cirrhotic patients]H Hirasawa, M Odaka, H Kobayashi, et al.
European Journal of Immunology|February 17, 2001
A complex composed of USF1 and USF2 activates the human FcepsilonRI alpha chain expression via a CAGCTG element in the first intronK Takahashi, C Nishiyama, M Nishiyama, et al.
Nihon Kyobu Shikkan Gakkai Zasshi|February 1, 1991
[Hemopurification in the management of ARDS complicating multiple organ failure]H Hirasawa, T Sugai, Y Ohtake, et al.
Contributions to Nephrology|January 1, 1991
Nafamostat mesylate as anticoagulant in continuous hemofiltration and continuous hemodiafiltrationY Ohtake, H Hirasawa, T Sugai, et al.
Clinical Nephrology|June 11, 1999
Hepatocellular carcinoma among hemodialysis patients infected with hepatitis C virus--early evolution and rapid progressionH Hayashi, Y Ohtake, T Kashima, et al.
Clinical and Experimental Dialysis and Apheresis|January 1, 1983
Experimental and clinical study on ATP-MgCl2 administration for postischemic acute renal failureH Hirasawa, M Odaka, K Soeda, et al.
ASAIO Transactions|July 1, 1990
A muscle powered cardiac assist device for right ventricular support: total assist or partial assist?N Sakakibara, G Watanabe, T Misaki, et al.
Artificial Organs|October 1, 1988
Prognostic value of serum osmolality gap in patients with multiple organ failure treated with hemopurificationH Hirasawa, M Odaka, T Sugai, et al.
Biological & Pharmaceutical Bulletin|August 21, 2001
Histopathological study of kidney abnormalities in an experimental SIADH rat model and its application to the evaluation of the pharmacologic profile of VP-343, a selective vasopressin V2 receptor antagonistA Naito, H Hasegawa, T Kurasawa, et al.
Pageof 10